四联疗法联合康复新液治疗幽门螺杆菌相关性溃疡患者的效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of quadruple therapy combined with Kangfuxin Liquid in patients with Helicobacter pylori-related ulcer.Methods A total of 56 patients with gastric and duodenal bulb ulcers admitted to the Shangrao Municipal Hospital from March 2018 to March 2020 as the research objects,and divided into the control group and the observation group according to the random number table method,with 28 cases in each group.The control group was treated with quadruple therapy,and the observation group as treated with quadruple therapy combined with Kangfuxin Liquid.The total effective rate, Helicobacter pylori eradication rate and recurrence rate,and total incidence of adverse reactions were compared between the two groups.Results After the treatment,the total effective rate of the observation group was 92.86%,which was higher than 67.87% of the control group,and the differences were statistically significant(P<0.05).The Helicobacter pylori clearance rate of the observation group was 96.43%,which was higher than 71.42% of the control group,and the differences were statistically significant(P<0.05).The recurernce rate of the observation group was 7.14%,which was lower than 28.57% of the control group,and the differences were statistically significant(P<0.05).The total incidence of adverse reactions of the observation group was 7.14%,lower than 28.57% of the control group,and the differences were statistically significant(P<0.05).Conclusion In patients with Helicobacter pylori associated ulcer disease,quadruple therapy combined with Kangfuxin Liquid could significantly improve the clinical efficacy,improve Helicobacter pylori,reduce the recurrence rate of Helicobacter pylori,and effectively reduce the incidence of adverse reactions,and the clinical application value is significant.

Key words： Quadruple therapy Kangfuxin Liquid Helicobacter pylori associated ulcer Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YI Zhen

Cite this article:

YI Zhen. Effect of quadruple therapy combined with Kangfuxin Liquid in patients with Helicobacter pylori-related ulcer[J]. 中国当代医药, 2021, 28(25): 56-58转62.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I25/56

[1]	廖怀利.康复新液联合四联疗法杀幽门螺旋杆菌的疗效观察[J].当代医学，2018，24（12）：101-103.
[2]	赵文强.康复新液联合四联疗法治疗幽门螺杆菌阳性慢性萎缩性胃炎临床研究[J].新中医，2020，52（4）：67-70.
[3]	钟小艳.两种四联疗法治疗幽门螺杆菌相关性胃溃疡的疗效比较[J].心理医生，2019，25（2）：172-173.
[4]	王传钧.中药联合四联疗法治疗幽门螺旋杆菌相关性胃溃疡观察[J].饮食保健，2018，5（35）：52-53.
[5]	刘健丽，林均余，蒋宇波.康复新液加四联疗法治疗消化性溃疡合并幽门螺杆菌感染的临床观察[J].深圳中西医结合杂志，2018，28（7）：166-167.
[6]	张海滨，柳明方.四联疗法治疗幽门螺杆菌相关性胃溃疡的效果分析[J].当代医药论丛，2020，18（8）：128-129.
[7]	盛丽华.康复新液联合杀灭幽门螺杆菌治疗慢性萎缩性胃炎的临床疗效观察[J].中国社区医师，2019，35（11）：89，92.
[8]	梁勇.四联疗法治疗幽门罗杆菌相关性胃溃疡的疗效[J].中国保健营养，2018，28（34）：32.
[9]	韩少伟.埃索美拉唑四联疗法联合康复新液对幽门螺杆菌阳性慢性胃炎患者胃泌素及炎性因子的影响[J].中国执业药师，2019，16（6）：53-55，58.
[10]	吴际，刘君君，李艳，等.益生菌联合铋剂四联疗法根除幽门螺杆菌的临床研究[J].中国医药科学，2020，10（3）：70-73.
[11]	陈平琅.幽门螺杆菌四联疗法联合安胃汤治疗幽门螺杆菌相关性胃溃疡的疗效分析[J].中国药物与临床，2019，19（20）：3534-3536.
[12]	杨勇，毛云高.奥美拉唑联合内镜下止血夹治疗消化性溃疡并出血的疗效[J].中国现代医生，2019，57（10）：102-104，108.
[13]	苏成霞,章茜,聂璐,陈建辉,涂华,胡运莲.武汉地区2018—2019年幽门螺杆菌菌株耐药性分析[J].中国现代医生，2021，59（16）：23-26，31.
[14]	施彦卿，刘斌，张蒙蒙，等.康复新液联合奥美拉唑治疗非幽门螺杆菌感染消化性溃疡的临床效果[J].中国当代医药，2019，26（3）：123-125.
[15]	田明忠.胃铋镁四联疗法治疗幽门螺杆菌相关性消化性溃疡的临床效果评价[J].医药前沿，2018，8（31）：199-200.
[16]	张瑞林.康复新液联合三联疗法治疗幽门螺杆菌相关十二指肠球部溃疡的效果探讨[J].中国现代医生，2019，57（28）：47-49.